Chimerix Inc (CMRX)
0.9162
+0.02
(+1.80%)
USD |
NASDAQ |
Oct 04, 16:00
0.9047
-0.01
(-1.26%)
After-Hours: 20:00
Chimerix Shareholders Equity (Annual): 193.03M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 193.03M |
| December 31, 2022 | 256.86M |
| December 31, 2021 | 68.25M |
| December 31, 2020 | 73.38M |
| December 31, 2019 | 109.95M |
| December 31, 2018 | 177.60M |
| December 31, 2017 | 221.81M |
| Date | Value |
|---|---|
| December 31, 2016 | 276.22M |
| December 31, 2015 | 335.46M |
| December 31, 2014 | 274.64M |
| December 31, 2013 | 98.54M |
| December 31, 2012 | 6.692M |
| December 31, 2011 | 9.686M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
68.25M
Minimum
2021
256.86M
Maximum
2022
140.29M
Average
109.95M
Median
2019
Shareholders Equity (Annual) Benchmarks
| SIGA Technologies Inc | 196.86M |
| Abbott Laboratories | 38.60B |
| Emergent BioSolutions Inc | 649.30M |
| Tonix Pharmaceuticals Holding Corp | 105.52M |
| Marinus Pharmaceuticals Inc | 16.76M |